Structure

Physi-Chem Properties

Molecular Weight:  808.29
Volume:  795.939
LogP:  1.739
LogD:  2.005
LogS:  -4.474
# Rotatable Bonds:  20
TPSA:  221.52
# H-Bond Aceptor:  16
# H-Bond Donor:  6
# Rings:  5
# Heavy Atoms:  16

MedChem Properties

QED Drug-Likeness Score:  0.055
Synthetic Accessibility Score:  4.998
Fsp3:  0.357
Lipinski Rule-of-5:  Rejected
Pfizer Rule:  Accepted
GSK Rule:  Rejected
BMS Rule:  1
Golden Triangle Rule:  Rejected
Chelating Alert:  1
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.672
MDCK Permeability:  1.9399318262003362e-05
Pgp-inhibitor:  0.993
Pgp-substrate:  0.992
Human Intestinal Absorption (HIA):  0.624
20% Bioavailability (F20%):  0.004
30% Bioavailability (F30%):  0.046

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.172
Plasma Protein Binding (PPB):  58.875030517578125%
Volume Distribution (VD):  0.557
Pgp-substrate:  65.7569351196289%

ADMET: Metabolism

CYP1A2-inhibitor:  0.002
CYP1A2-substrate:  0.158
CYP2C19-inhibitor:  0.013
CYP2C19-substrate:  0.915
CYP2C9-inhibitor:  0.033
CYP2C9-substrate:  0.764
CYP2D6-inhibitor:  0.0
CYP2D6-substrate:  0.657
CYP3A4-inhibitor:  0.699
CYP3A4-substrate:  0.943

ADMET: Excretion

Clearance (CL):  5.125
Half-life (T1/2):  0.391

ADMET: Toxicity

hERG Blockers:  0.201
Human Hepatotoxicity (H-HT):  0.132
Drug-inuced Liver Injury (DILI):  0.136
AMES Toxicity:  0.068
Rat Oral Acute Toxicity:  0.527
Maximum Recommended Daily Dose:  0.763
Skin Sensitization:  0.278
Carcinogencity:  0.023
Eye Corrosion:  0.003
Eye Irritation:  0.006
Respiratory Toxicity:  0.011

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC470828

Natural Product ID:  NPC470828
Common Name*:   5''-Methoxy-4''-O-(8-Guaiacylglycerol)Buddlenol A
IUPAC Name:   (E)-3-[(2R,3S)-2-[4-[1-[4-[1,3-dihydroxy-1-(4-hydroxy-3-methoxyphenyl)propan-2-yl]oxy-3,5-dimethoxyphenyl]-1,3-dihydroxypropan-2-yl]oxy-3,5-dimethoxyphenyl]-3-(hydroxymethyl)-7-methoxy-2,3-dihydro-1-benzofuran-5-yl]prop-2-enal
Synonyms:  
Standard InCHIKey:  ZCFXYUOLSAFDRL-ZXJVSXSISA-N
Standard InCHI:  InChI=1S/C42H48O16/c1-50-29-14-23(9-10-28(29)47)37(48)35(20-45)56-41-31(52-3)15-24(16-32(41)53-4)38(49)36(21-46)57-42-33(54-5)17-25(18-34(42)55-6)39-27(19-44)26-12-22(8-7-11-43)13-30(51-2)40(26)58-39/h7-18,27,35-39,44-49H,19-21H2,1-6H3/b8-7+/t27-,35?,36?,37?,38?,39+/m1/s1
SMILES:  COC1=CC(=CC2=C1OC(C2CO)C3=CC(=C(C(=C3)OC)OC(CO)C(C4=CC(=C(C(=C4)OC)OC(CO)C(C5=CC(=C(C=C5)O)OC)O)OC)O)OC)C=CC=O
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL225532
PubChem CID:   16216401
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000261] Phenylpropanoids and polyketides
      • [CHEMONTID:0003405] 2-arylbenzofuran flavonoids

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO14922 Tarenna attenuata Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[16792422]
NPO14922 Tarenna attenuata Species Rubiaceae Eukaryota n.a. n.a. n.a. PMID[17343407]
NPO14922 Tarenna attenuata Species Rubiaceae Eukaryota n.a. n.a. n.a. Database[UNPD]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT681 Cell Line PC-12 Rattus norvegicus Activity = 50.3 % PMID[464145]
NPT681 Cell Line PC-12 Rattus norvegicus Activity = 54.7 % PMID[464145]
NPT681 Cell Line PC-12 Rattus norvegicus Activity = 55.2 % PMID[464145]
NPT681 Cell Line PC-12 Rattus norvegicus Activity = 51.0 % PMID[464145]
NPT1 Others Radical scavenging activity IC50 = 127000.0 nM PMID[464145]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC470828 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9933 High Similarity NPC470827
0.9667 High Similarity NPC470769
0.9542 High Similarity NPC125495
0.9333 High Similarity NPC473408
0.9281 High Similarity NPC115203
0.9276 High Similarity NPC329343
0.9276 High Similarity NPC321972
0.9276 High Similarity NPC324517
0.9211 High Similarity NPC477612
0.92 High Similarity NPC260397
0.9145 High Similarity NPC473266
0.9145 High Similarity NPC470098
0.9145 High Similarity NPC470826
0.9133 High Similarity NPC181615
0.9079 High Similarity NPC20757
0.9079 High Similarity NPC227516
0.9067 High Similarity NPC264706
0.9067 High Similarity NPC284881
0.9067 High Similarity NPC474444
0.9067 High Similarity NPC93433
0.902 High Similarity NPC475250
0.902 High Similarity NPC211561
0.9013 High Similarity NPC320671
0.9013 High Similarity NPC328567
0.9013 High Similarity NPC327412
0.9013 High Similarity NPC320970
0.9006 High Similarity NPC43065
0.8994 High Similarity NPC478267
0.8974 High Similarity NPC157333
0.8968 High Similarity NPC279406
0.8968 High Similarity NPC226809
0.8957 High Similarity NPC180768
0.8954 High Similarity NPC102934
0.8954 High Similarity NPC252402
0.8947 High Similarity NPC317053
0.8947 High Similarity NPC324492
0.891 High Similarity NPC224161
0.8889 High Similarity NPC236202
0.8889 High Similarity NPC59516
0.8889 High Similarity NPC170103
0.8889 High Similarity NPC204770
0.8889 High Similarity NPC82917
0.8889 High Similarity NPC108811
0.8889 High Similarity NPC58190
0.8889 High Similarity NPC202742
0.8889 High Similarity NPC263940
0.8889 High Similarity NPC262911
0.8889 High Similarity NPC294558
0.8889 High Similarity NPC70409
0.8889 High Similarity NPC18185
0.8868 High Similarity NPC478269
0.8867 High Similarity NPC263261
0.8867 High Similarity NPC87725
0.8867 High Similarity NPC470372
0.8854 High Similarity NPC46335
0.8831 High Similarity NPC329836
0.8824 High Similarity NPC96576
0.882 High Similarity NPC12326
0.8816 High Similarity NPC114119
0.8816 High Similarity NPC15659
0.8816 High Similarity NPC304894
0.8816 High Similarity NPC471415
0.8816 High Similarity NPC470097
0.8808 High Similarity NPC278469
0.8808 High Similarity NPC193722
0.88 High Similarity NPC267291
0.88 High Similarity NPC291101
0.88 High Similarity NPC22317
0.88 High Similarity NPC266197
0.8797 High Similarity NPC202104
0.8758 High Similarity NPC216916
0.8758 High Similarity NPC274960
0.8758 High Similarity NPC473909
0.8758 High Similarity NPC163898
0.8758 High Similarity NPC143120
0.875 High Similarity NPC163508
0.875 High Similarity NPC173203
0.8742 High Similarity NPC178054
0.8742 High Similarity NPC83375
0.8742 High Similarity NPC224876
0.8733 High Similarity NPC260842
0.871 High Similarity NPC281549
0.871 High Similarity NPC236166
0.8701 High Similarity NPC40222
0.8701 High Similarity NPC268515
0.8693 High Similarity NPC28440
0.8693 High Similarity NPC171932
0.8693 High Similarity NPC93323
0.8693 High Similarity NPC12641
0.8693 High Similarity NPC45257
0.8693 High Similarity NPC63879
0.8693 High Similarity NPC280092
0.8688 High Similarity NPC73517
0.8688 High Similarity NPC4809
0.8688 High Similarity NPC147743
0.8675 High Similarity NPC309124
0.8675 High Similarity NPC184797
0.8671 High Similarity NPC475141
0.8667 High Similarity NPC477938
0.8667 High Similarity NPC474390
0.8654 High Similarity NPC476969
0.8654 High Similarity NPC318373
0.8654 High Similarity NPC321657
0.865 High Similarity NPC45943
0.8645 High Similarity NPC16269
0.8645 High Similarity NPC21776
0.8645 High Similarity NPC101376
0.8642 High Similarity NPC149873
0.8642 High Similarity NPC7191
0.8634 High Similarity NPC212614
0.8634 High Similarity NPC151474
0.8634 High Similarity NPC185231
0.8634 High Similarity NPC159526
0.8634 High Similarity NPC86630
0.8634 High Similarity NPC106601
0.8634 High Similarity NPC205613
0.8634 High Similarity NPC471404
0.8627 High Similarity NPC85264
0.8627 High Similarity NPC47633
0.8627 High Similarity NPC102044
0.8618 High Similarity NPC311530
0.8616 High Similarity NPC473736
0.8616 High Similarity NPC268484
0.8609 High Similarity NPC236306
0.8609 High Similarity NPC473739
0.8609 High Similarity NPC70682
0.8609 High Similarity NPC260741
0.8609 High Similarity NPC232164
0.8609 High Similarity NPC22517
0.8608 High Similarity NPC157783
0.8608 High Similarity NPC46283
0.8608 High Similarity NPC322899
0.8608 High Similarity NPC44192
0.8608 High Similarity NPC469944
0.8608 High Similarity NPC226108
0.8608 High Similarity NPC272552
0.8608 High Similarity NPC134911
0.8608 High Similarity NPC59692
0.86 High Similarity NPC29799
0.86 High Similarity NPC209985
0.86 High Similarity NPC156502
0.86 High Similarity NPC77861
0.86 High Similarity NPC263367
0.86 High Similarity NPC177160
0.86 High Similarity NPC477939
0.86 High Similarity NPC54743
0.86 High Similarity NPC10737
0.8599 High Similarity NPC472709
0.8599 High Similarity NPC472710
0.859 High Similarity NPC476348
0.859 High Similarity NPC187398
0.8589 High Similarity NPC476372
0.8589 High Similarity NPC476371
0.8571 High Similarity NPC473108
0.8562 High Similarity NPC475891
0.8562 High Similarity NPC67467
0.8562 High Similarity NPC107161
0.8562 High Similarity NPC2613
0.8562 High Similarity NPC59841
0.8562 High Similarity NPC131971
0.8562 High Similarity NPC204347
0.8553 High Similarity NPC160283
0.8553 High Similarity NPC254759
0.8553 High Similarity NPC472091
0.8553 High Similarity NPC472090
0.8553 High Similarity NPC472092
0.8553 High Similarity NPC223720
0.8553 High Similarity NPC262189
0.8553 High Similarity NPC306267
0.8553 High Similarity NPC20050
0.8544 High Similarity NPC2745
0.8544 High Similarity NPC302915
0.8533 High Similarity NPC125579
0.8533 High Similarity NPC93783
0.8528 High Similarity NPC469889
0.8526 High Similarity NPC262297
0.8526 High Similarity NPC476347
0.8519 High Similarity NPC241600
0.8519 High Similarity NPC215400
0.8519 High Similarity NPC230531
0.8519 High Similarity NPC173726
0.8516 High Similarity NPC469557
0.8512 High Similarity NPC98583
0.8509 High Similarity NPC165483
0.8509 High Similarity NPC11411
0.8506 High Similarity NPC477616
0.8503 High Similarity NPC102277
0.8503 High Similarity NPC279209
0.85 High Similarity NPC8712
0.8497 Intermediate Similarity NPC247291
0.8497 Intermediate Similarity NPC471389
0.8497 Intermediate Similarity NPC100482
0.8497 Intermediate Similarity NPC277331
0.8497 Intermediate Similarity NPC35216
0.8491 Intermediate Similarity NPC160196
0.8491 Intermediate Similarity NPC476391
0.8491 Intermediate Similarity NPC120774
0.8491 Intermediate Similarity NPC264875
0.8491 Intermediate Similarity NPC163598
0.8491 Intermediate Similarity NPC476434

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC470828 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.8212 Intermediate Similarity NPD1613 Approved
0.8212 Intermediate Similarity NPD1612 Clinical (unspecified phase)
0.8133 Intermediate Similarity NPD3027 Phase 3
0.8079 Intermediate Similarity NPD4907 Clinical (unspecified phase)
0.8061 Intermediate Similarity NPD4868 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD6168 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD6167 Clinical (unspecified phase)
0.8047 Intermediate Similarity NPD6166 Phase 2
0.8023 Intermediate Similarity NPD7993 Clinical (unspecified phase)
0.7947 Intermediate Similarity NPD1529 Clinical (unspecified phase)
0.7947 Intermediate Similarity NPD4908 Phase 1
0.7939 Intermediate Similarity NPD2393 Clinical (unspecified phase)
0.7907 Intermediate Similarity NPD5844 Phase 1
0.7881 Intermediate Similarity NPD1530 Clinical (unspecified phase)
0.7879 Intermediate Similarity NPD1934 Approved
0.7857 Intermediate Similarity NPD6234 Discontinued
0.7853 Intermediate Similarity NPD1653 Approved
0.7849 Intermediate Similarity NPD3818 Discontinued
0.7849 Intermediate Similarity NPD7228 Approved
0.7811 Intermediate Similarity NPD5494 Approved
0.7784 Intermediate Similarity NPD8443 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD6559 Discontinued
0.7771 Intermediate Similarity NPD37 Approved
0.7765 Intermediate Similarity NPD7199 Phase 2
0.7759 Intermediate Similarity NPD7472 Approved
0.7759 Intermediate Similarity NPD7074 Phase 3
0.7738 Intermediate Similarity NPD4966 Approved
0.7738 Intermediate Similarity NPD3882 Suspended
0.7738 Intermediate Similarity NPD4967 Phase 2
0.7738 Intermediate Similarity NPD7768 Phase 2
0.7738 Intermediate Similarity NPD4965 Approved
0.7701 Intermediate Similarity NPD7054 Approved
0.7661 Intermediate Similarity NPD8127 Discontinued
0.7651 Intermediate Similarity NPD4380 Phase 2
0.7627 Intermediate Similarity NPD7808 Phase 3
0.7619 Intermediate Similarity NPD8455 Phase 2
0.7619 Intermediate Similarity NPD2801 Approved
0.7598 Intermediate Similarity NPD8055 Clinical (unspecified phase)
0.7586 Intermediate Similarity NPD7473 Discontinued
0.7578 Intermediate Similarity NPD6674 Discontinued
0.7572 Intermediate Similarity NPD7184 Clinical (unspecified phase)
0.7571 Intermediate Similarity NPD7251 Discontinued
0.7562 Intermediate Similarity NPD7266 Discontinued
0.7558 Intermediate Similarity NPD6959 Discontinued
0.7514 Intermediate Similarity NPD6797 Phase 2
0.7514 Intermediate Similarity NPD6232 Discontinued
0.7486 Intermediate Similarity NPD8313 Approved
0.7486 Intermediate Similarity NPD8312 Approved
0.7485 Intermediate Similarity NPD7075 Discontinued
0.7483 Intermediate Similarity NPD1610 Phase 2
0.7473 Intermediate Similarity NPD8397 Clinical (unspecified phase)
0.7472 Intermediate Similarity NPD7240 Approved
0.7468 Intermediate Similarity NPD5123 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD5124 Phase 1
0.743 Intermediate Similarity NPD7549 Discontinued
0.7429 Intermediate Similarity NPD7852 Clinical (unspecified phase)
0.7419 Intermediate Similarity NPD2861 Phase 2
0.7412 Intermediate Similarity NPD1465 Phase 2
0.7412 Intermediate Similarity NPD7819 Suspended
0.7405 Intermediate Similarity NPD4060 Phase 1
0.7401 Intermediate Similarity NPD7804 Clinical (unspecified phase)
0.7394 Intermediate Similarity NPD1511 Approved
0.7389 Intermediate Similarity NPD6410 Clinical (unspecified phase)
0.7384 Intermediate Similarity NPD4381 Clinical (unspecified phase)
0.7368 Intermediate Similarity NPD3817 Phase 2
0.7349 Intermediate Similarity NPD7410 Clinical (unspecified phase)
0.7333 Intermediate Similarity NPD4338 Clinical (unspecified phase)
0.7325 Intermediate Similarity NPD4625 Phase 3
0.731 Intermediate Similarity NPD7096 Clinical (unspecified phase)
0.7305 Intermediate Similarity NPD1512 Approved
0.7296 Intermediate Similarity NPD3620 Phase 2
0.7296 Intermediate Similarity NPD3619 Clinical (unspecified phase)
0.7294 Intermediate Similarity NPD7411 Suspended
0.7273 Intermediate Similarity NPD4379 Clinical (unspecified phase)
0.7262 Intermediate Similarity NPD6980 Clinical (unspecified phase)
0.7256 Intermediate Similarity NPD5698 Clinical (unspecified phase)
0.7253 Intermediate Similarity NPD8054 Approved
0.7253 Intermediate Similarity NPD8053 Approved
0.7251 Intermediate Similarity NPD6801 Discontinued
0.7246 Intermediate Similarity NPD4378 Clinical (unspecified phase)
0.7246 Intermediate Similarity NPD7422 Clinical (unspecified phase)
0.7226 Intermediate Similarity NPD8651 Approved
0.7219 Intermediate Similarity NPD1548 Phase 1
0.7216 Intermediate Similarity NPD7229 Phase 3
0.7212 Intermediate Similarity NPD6398 Clinical (unspecified phase)
0.7197 Intermediate Similarity NPD3018 Phase 2
0.7188 Intermediate Similarity NPD7680 Approved
0.7186 Intermediate Similarity NPD6143 Clinical (unspecified phase)
0.7182 Intermediate Similarity NPD7685 Pre-registration
0.7174 Intermediate Similarity NPD8434 Phase 2
0.7169 Intermediate Similarity NPD6190 Approved
0.7168 Intermediate Similarity NPD5402 Approved
0.7161 Intermediate Similarity NPD4749 Approved
0.7159 Intermediate Similarity NPD1247 Approved
0.7152 Intermediate Similarity NPD1652 Phase 2
0.7143 Intermediate Similarity NPD7004 Clinical (unspecified phase)
0.7143 Intermediate Similarity NPD919 Approved
0.7135 Intermediate Similarity NPD7906 Approved
0.7134 Intermediate Similarity NPD5762 Approved
0.7134 Intermediate Similarity NPD5763 Approved
0.7108 Intermediate Similarity NPD3750 Approved
0.7108 Intermediate Similarity NPD8166 Discontinued
0.7091 Intermediate Similarity NPD2424 Discontinued
0.7091 Intermediate Similarity NPD1549 Phase 2
0.7086 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7079 Intermediate Similarity NPD3926 Phase 2
0.7076 Intermediate Similarity NPD5808 Clinical (unspecified phase)
0.7069 Intermediate Similarity NPD6374 Clinical (unspecified phase)
0.7068 Intermediate Similarity NPD7237 Clinical (unspecified phase)
0.7063 Intermediate Similarity NPD6859 Clinical (unspecified phase)
0.7059 Intermediate Similarity NPD5403 Approved
0.7055 Intermediate Similarity NPD7097 Phase 1
0.7051 Intermediate Similarity NPD2982 Phase 2
0.7051 Intermediate Similarity NPD2983 Phase 2
0.7048 Intermediate Similarity NPD7421 Clinical (unspecified phase)
0.7041 Intermediate Similarity NPD7447 Phase 1
0.7037 Intermediate Similarity NPD5735 Approved
0.7037 Intermediate Similarity NPD6355 Discontinued
0.7032 Intermediate Similarity NPD422 Phase 1
0.703 Intermediate Similarity NPD1550 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD1552 Clinical (unspecified phase)
0.7025 Intermediate Similarity NPD6917 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD7879 Clinical (unspecified phase)
0.7012 Intermediate Similarity NPD5588 Approved
0.7006 Intermediate Similarity NPD4628 Phase 3
0.7006 Intermediate Similarity NPD7466 Approved
0.7 Intermediate Similarity NPD5283 Phase 1
0.6994 Remote Similarity NPD7615 Clinical (unspecified phase)
0.6989 Remote Similarity NPD4663 Approved
0.6989 Remote Similarity NPD3749 Approved
0.6987 Remote Similarity NPD2981 Phase 2
0.6982 Remote Similarity NPD4357 Discontinued
0.6982 Remote Similarity NPD7213 Phase 3
0.6982 Remote Similarity NPD7212 Phase 2
0.6977 Remote Similarity NPD6055 Clinical (unspecified phase)
0.6973 Remote Similarity NPD7090 Clinical (unspecified phase)
0.697 Remote Similarity NPD2796 Approved
0.697 Remote Similarity NPD6099 Approved
0.697 Remote Similarity NPD6100 Approved
0.6961 Remote Similarity NPD3751 Discontinued
0.6957 Remote Similarity NPD6798 Discontinued
0.6951 Remote Similarity NPD4536 Approved
0.6951 Remote Similarity NPD4537 Clinical (unspecified phase)
0.6951 Remote Similarity NPD4538 Approved
0.6944 Remote Similarity NPD2489 Approved
0.6944 Remote Similarity NPD27 Approved
0.6941 Remote Similarity NPD5401 Approved
0.6941 Remote Similarity NPD7446 Clinical (unspecified phase)
0.6933 Remote Similarity NPD7843 Approved
0.6927 Remote Similarity NPD3051 Approved
0.6927 Remote Similarity NPD3787 Discontinued
0.6923 Remote Similarity NPD5058 Phase 3
0.6923 Remote Similarity NPD8156 Discontinued
0.6919 Remote Similarity NPD4578 Approved
0.6919 Remote Similarity NPD7310 Approved
0.6919 Remote Similarity NPD7311 Approved
0.6919 Remote Similarity NPD4577 Approved
0.6919 Remote Similarity NPD7312 Approved
0.6919 Remote Similarity NPD7313 Approved
0.6919 Remote Similarity NPD8151 Discontinued
0.6909 Remote Similarity NPD1510 Phase 2
0.6908 Remote Similarity NPD7157 Approved
0.6905 Remote Similarity NPD6331 Phase 2
0.6901 Remote Similarity NPD7314 Clinical (unspecified phase)
0.6901 Remote Similarity NPD6273 Approved
0.6894 Remote Similarity NPD7095 Approved
0.6889 Remote Similarity NPD2970 Approved
0.6889 Remote Similarity NPD2969 Approved
0.6882 Remote Similarity NPD6799 Approved
0.6882 Remote Similarity NPD7309 Approved
0.6881 Remote Similarity NPD7047 Phase 3
0.6875 Remote Similarity NPD8090 Clinical (unspecified phase)
0.6871 Remote Similarity NPD4140 Approved
0.6868 Remote Similarity NPD8099 Discontinued
0.6868 Remote Similarity NPD8251 Approved
0.6868 Remote Similarity NPD8252 Approved
0.6867 Remote Similarity NPD2935 Discontinued
0.6867 Remote Similarity NPD1551 Phase 2
0.6867 Remote Similarity NPD228 Approved
0.6862 Remote Similarity NPD6842 Approved
0.6862 Remote Similarity NPD6841 Approved
0.6862 Remote Similarity NPD6843 Phase 3
0.6842 Remote Similarity NPD2532 Approved
0.6842 Remote Similarity NPD2534 Approved
0.6842 Remote Similarity NPD4160 Clinical (unspecified phase)
0.6842 Remote Similarity NPD2533 Approved
0.6839 Remote Similarity NPD6599 Discontinued
0.6835 Remote Similarity NPD3600 Clinical (unspecified phase)
0.6829 Remote Similarity NPD230 Phase 1
0.6826 Remote Similarity NPD6005 Phase 3
0.6826 Remote Similarity NPD6006 Clinical (unspecified phase)
0.6826 Remote Similarity NPD6004 Phase 3
0.6826 Remote Similarity NPD2343 Clinical (unspecified phase)
0.6826 Remote Similarity NPD6002 Phase 3
0.6826 Remote Similarity NPD6003 Clinical (unspecified phase)
0.6818 Remote Similarity NPD5536 Phase 2
0.6815 Remote Similarity NPD3705 Approved
0.6815 Remote Similarity NPD1091 Approved
0.681 Remote Similarity NPD6233 Phase 2
0.6807 Remote Similarity NPD5960 Phase 3

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data